Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Lymphoma, Large B-Cell, Diffuse 9Hodgkin Disease 7Sarcoma 6Lymphoma 6Testicular Neoplasms 5Testicular Germ Cell Tumor 5Ovarian Neoplasms 5Osteosarcoma 5Lymphoma, Follicular 5Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Anaplastic 4Burkitt Lymphoma 4Recurrence 3Lymphoma, Large-Cell, Immunoblastic 3Immunoblastic Lymphadenopathy 3Central Nervous System Neoplasms 3Waldenstrom Macroglobulinemia 2Teratoma 2Solitary Fibrous Tumors 2Small Cell Lung Carcinoma 2Sarcoma, Clear Cell 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Lymphoma, Extranodal NK-T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hemangiosarcoma 2Hemangioendothelioma, Epithelioid 2Dendritic Cell Sarcoma, Interdigitating 2

Interventions

pazopanib 1Ifosfamide 1Etoposide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Relapsed Pediatric Solid Tumor × Ifosfamide × Clear all
NCT03628131 2018-09-19

Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors

Samsung Medical Center

Phase 1/2 Unknown
46 enrolled
Other solid neoplasm

Relapsed Pediatric Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡